Publications by authors named "F Jamal"

Claim this Profile
E
Evaluating third-line therapies in refractory metastatic colorectal cancer: a systematic review and network meta-analysis.
Celine Hoyek, Syed Arsalan Ahmed Naqvi, Oudai Sahvan, Fares Jamal, Kunwer Sufyan Faisal

Dig Liver Dis· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomarker-Guided Cardioprotection for Patients Treated With Anthracyclines: A Randomized Clinical Trial.
Congying Xia, Amanda M Smith, Bénédicte Lefebvre, Faizi A Jamal, Saro H Armenian

JAMA Netw Open· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating Food and Drug Administration approved gastrointestinal cancer drugs: clinical benefit and trial endpoints over the past two decades.
Fares Jamal, Oudai Sahvan, Pedro Luiz Serrano Uson Junior, Jeremy C Jones, Fang-Shu Ou

Oncologist· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune Checkpoint Inhibitors for Mismatch Repair-Deficient Gastroesophageal Adenocarcinoma: Outcomes and Feasibility of Nonoperative Management at Mayo Clinic.
Oudai Sahwan, Fares Jamal, Rish Pai, Cody Eslinger, Shaylene McCue

JCO Precis Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating Tumor DNA (ctDNA) in Gastroesophageal Adenocarcinoma (GEA): Evidence and Emerging Applications.
Oudai Sahwan, Lin Batha, Fares Jamal, Mohamad Bassam Sonbol

Cancers (Basel)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis